Results 221 to 230 of about 4,979,977 (315)

Foods to Prevent Cardiometabolic Disease: Moving from "Saturated Fat" to "Whole Foods". [PDF]

Curr Dev Nutr
Astrup A, Abodi M, Mazzocchi A, Agostoni C, Brenna JT, Krauss RM, Hill JO, Eckel RH.   +7 more
europepmc   +1 more source

Diagnostic Accuracy of Serum‐Based Fibrosis Scores for Clinically Significant Liver Fibrosis in an East Asian Cohort

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Serum‐based fibrosis scores are widely used for noninvasive risk stratification in chronic liver disease; however, direct comparisons across liver disease etiologies remain limited, particularly in Asian populations with a high prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection.
Sheng‐Feng Lin, Chun‐Chao Chang
wiley   +1 more source

Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes. [PDF]

Nat Metab
Landman JM, Highland HM, Perry AS, Howard AG, Sheng Q, Lorenz A, Palmer AB, Zhao S, Zhu W, Zhang X, Buchanan VL, Frankel EG, Roshani R, Scartozzi A, Farber-Eger EH, Anwar MY, Sprinkles JK, Breidenbach A, Wang TC, Ballard CA, Nayor M, Tamaroff J, Gutierrez A, Petty LE, Petty AS, Lippi B, Fernandez-Rhodes L, Chen HH, Krishnan M, Graff M, Meyer KA, Lee M, Young KL, Wells Q, Tanriverdi K, Freedman JE, Gamazon ER, McCormick JB, Fisher-Hoch SP, Gordon-Larsen P, Below JE, North KE, Shah RV.   +42 more
europepmc   +1 more source

Circulating Omega‐3 Fatty Acids and Cardiometabolic Outcomes: A Systematic Review of Publications From UK Biobank

Lipids, EarlyView.
ABSTRACT Studies have shown that omega‐3 fatty acids may protect against cardiovascular diseases (CVDs) and related metabolic conditions. UK Biobank is a large cohort study that includes data on plasma omega‐3 fatty acids at study entry and health outcomes during the follow‐up period.
Warda Tul Firdous, Philip C. Calder
wiley   +1 more source

Addiction as a cardiometabolic disease: a neurocardiometabolic framework and the emerging role of GLP-1 receptor therapies. [PDF]

Eur Heart J Open
Seijas-Amigo J, Salgado-Barreira Á, Eiras S, Arias-Rivas S, Rodriguez-Carnero G, Rodriguez-Mañero M, Gonzalez-Juanatey JR.   +6 more
europepmc   +1 more source

Prevalence and risk factors of cardiometabolic disease among informal sector workers in Cape Coast, Ghana: Insights from the CarMeR study. [PDF]

PLoS One
Hormenu T, Antiri EO, Awlime-Ableh E, Paku JE, Nartey EE, Bukari S, Amegah AK.   +6 more
europepmc   +1 more source

Proteoforms in Disease: Biomedical Applications of Top‐Down Proteomics

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The proteome is a dynamic landscape of proteoforms arising from genetic mutations, alternative splicing, and post‐translational modifications (PTMs), which collectively drive biological function and disease phenotypes. Mass spectrometry (MS)‐based proteomics has emerged as an essential technique for elucidating this molecular complexity ...
Holden T. Rogers, Zachery R. Gregorich, Megan S. Gant, Zhan Gao, Julia Chamot‐Rooke, Ying Ge   +5 more
wiley   +1 more source

Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank. [PDF]

Front Cardiovasc Med
Lin T, Hu S, Gong W, Li L, Zhu Z, Xie H, Zhao F.   +6 more
europepmc   +1 more source

Sleep‐Autonomic Interactions in Parkinson's Disease and Multiple System Atrophy: A Comparative Study Using Structural Equation Modeling

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) and multiple system atrophy (MSA) are α‐synucleinopathies with overlapping autonomic and sleep dysfunction, but distinct trajectories. Objectives This study compared sleep and autonomic profiles in PD and MSA and elucidated disease‐specific associations using structural equation modeling (SEM).
Bora Jin, Yoonkyung Lee, Seungho Lee, Byeol‐A Yoon, Young Jin Jeong, Sang‐Myung Cheon   +5 more
wiley   +1 more source

Ancestry, ethnicity, and race: explaining inequalities in cardiometabolic disease

Population differences in cardiometabolic disease remain unexplained. Misleading assumptions over genetic explanations are partly due to terminology used to distinguish populations, specifically ancestry, race, and ethnicity.
Scally, A, Hemani, G, Eastwood, SV, Chaturvedi, N, Davey Smith, G, Watkins, SH   +5 more
core